Soni Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider, approve and take ....
Awaiting price reaction for this filing.
Soni Medicare Ltd has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 at the registered office in Jaipur. The main agenda is to consider and approve the unaudited financial results for the quarter and half year ended 30 September 2025, along with the auditor's limited review report. The trading window for designated persons and their immediate relatives has been closed from 1 October 2025 and will remain closed until 48 hours after the board meeting concludes. The intimation is filed under Regulation 29 of SEBI LODR Regulations, 2015.
Investors should expect Q2 FY26 earnings from Soni Medicare around or shortly after 14 November 2025. The closed trading window signals that results may contain material information, and insiders are restricted from trading until the numbers are publicly released.